Highland Hills Adds Life Saving Screening

Highland Hills Adds Life Saving Screening

According to the Center for Disease Control, in 2018, 218,520 new cases of Lung and Bronchus cancer was reported and 142,080 people died of this cancer. Delta Health-Highland Hills is working diligently to lower negative outcomes by offering a Low-Dose CT (LDCT) Lung Cancer Screening.

LDCT is recommended for adult’s age 55 to 77 years who are asymptomatic with no signs or symptoms of lung disease, have a tobacco smoking history of at least 30 pack-years and/or a current smoker or have quit within the past 15 years. Eligible patients are covered for the Low-Dose CT Lung Cancer Screening by private insurance, Medicare, and Medicaid. The initial screening procedure requires a written order from the patient’s provider.

Josh Hammons, Chief Administrative Officer, states “Lung cancer statistics are not only horrifying but on the rise in our country. The Highland Hills team is working diligently to decrease the numbers in our area. Our goal at Delta Health-Highland Hills is to continue providing and updating our life-saving services to our community and region.”

Benefits include but not limited to: Lung cancer found by the LDCT is often at an earlier stage of the disease and has been proven to reduce the number of deaths from lung cancer in patients at high risks; the scanning is painless, non-invasive and fast, which is important if a patient has trouble holding their breath; and if cancer is found with screening, patients can more often undergo minimally invasive surgery and have less lung tissue removed.

For more information about the Low-Dose CT Lung Screening, call 662.562.3133.